XML 59 R44.htm IDEA: XBRL DOCUMENT v3.25.1
Net Loss per Share - Anti-Dilutive Securities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Excluded from the calculation of diluted net loss per share, due to anti-dilutive effect      
Total anti-dilutive shares of common stock equivalents 23,713,338 9,244,150 7,006,250
Expense from the revaluation of warrants $ 33,377    
Common Warrants (1)      
Excluded from the calculation of diluted net loss per share, due to anti-dilutive effect      
Total anti-dilutive shares of common stock equivalents 11,778,238    
Expense from the revaluation of warrants $ 33,400    
Outstanding Options      
Excluded from the calculation of diluted net loss per share, due to anti-dilutive effect      
Total anti-dilutive shares of common stock equivalents 11,935,100 9,244,150 7,006,250